Iron Deficiency Anemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Inflammatory Bowel Disease is the fastest growing sector, North America is the largest market

The Global Iron Deficiency Anemia Market, comprising therapeutic solutions like oral and parenteral iron formulations aimed at replenishing iron stores and normalizing hemoglobin levels, is projected to grow from USD 5.89 Billion in 2025 to USD 9.18 Billion by 2031, exhibiting a 7.68% CAGR. This growth is primarily driven by the escalating burden of chronic diseases and maternal health conditions necessitating consistent hematological intervention, alongside increasing awareness of nutritional deficits, with updated 2025 estimates indicating that 30.7% of women aged 15-49 years were affected by anemia globally.

Market Drivers

The increasing burden of Chronic Kidney Disease (CKD) and gastrointestinal disorders serves as a primary catalyst for market expansion, as these conditions frequently disrupt iron absorption and utilization, necessitating consistent iron supplementation for patients, exemplified by Akebia Therapeutics' Auryxia generating $152.2 million in net product revenues for full year 2024 in the renal care space. Concurrently, a heightened focus on maternal health and the management of pregnancy-related anemia significantly propels therapeutic adoption, with governmental and health organization mandates increasingly prioritizing screening and treatment; the World Health Organization reported that 35.5% of pregnant women aged 15-49 years worldwide were affected by anemia in 2023, which has spurred the uptake of novel oral formulations like Accrufer, reporting 153% year-over-year revenue growth to $29.3 million in 2024 for Shield Therapeutics.

Market Challenges

The adverse event profiles associated with standard iron replacement therapies present a direct and significant impediment to the Global Iron Deficiency Anemia Market's expansion. Oral iron formulations frequently induce severe gastrointestinal distress, leading to patient non-compliance and premature discontinuation, while intravenous administration carries risks of hypersensitivity reactions and necessitates clinical supervision, creating logistical obstacles that limit product uptake, especially in resource-constrained settings. These safety and tolerability issues prevent the market from fully capitalizing on the urgent therapeutic needs of high-risk demographics, such as the 35.5% of pregnant women aged 15-49 years globally affected by anemia, thereby restricting widespread adoption of effective iron therapies and hampering overall market revenue potential.

Market Trends

The market is witnessing an accelerated adoption of high-dose intravenous iron therapies, driven by the clinical need to streamline treatment protocols and minimize hospital visits by enabling complete iron repletion in a single administration, which significantly enhances outpatient efficiency, as reflected in Pharmacosmos' annual revenue surpassing DKK 3 billion, attributed to the global uptake of its high-dose monoferric formulation. Simultaneously, the competitive landscape is being reshaped by the market entry and expansion of biosimilar iron therapeutics, triggered by the expiration of patents for established branded intravenous treatments, which provides cost-effective options for healthcare systems and compels incumbents to adapt strategies, with CSL Limited reporting $527 million in iron product sales for the period, achieving volume growth despite intensifying generic competition.

Key Market Players

• AbbVie Inc.
• Pfizer Inc.
• Takeda Pharmaceutical Company Limited
• Novartis AG
• Amgen Inc.
• Bayer AG
• Fresenius Kabi AG
• Vifor Pharma Group
• Glenmark Pharmaceuticals Ltd.
• Dr. Reddy's Laboratories Ltd.

Report Scope

In this report, the Global Iron Deficiency Anemia Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Iron Deficiency Anemia Market, by Therapy Type:

• Oral Iron Therapy
• Parenteral Iron Therapy
• Red Blood Cell Transfusion
• Others

Iron Deficiency Anemia Market, by Therapy Areas:

• Obstetrics and Gynecology
• Oncology
• Congestive Heart Failure (CHF)
• Inflammatory Bowel Disease
• Renal
• Others

Iron Deficiency Anemia Market, by End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Iron Deficiency Anemia Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Iron Deficiency Anemia Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.